DISSEMINATED ENTEROVIRAL INFECTION

This adverse event was reported 18 times

These drugs are most commonly taken by patients reporting DISSEMINATED ENTEROVIRAL INFECTION:

# Drug Count
0 OBINUTUZUMAB 8
1 PREDNISONE 7
2 RITUXIMAB 7
3 BENDAMUSTINE HCL 3
4 CISPLATIN 3
5 CYCLOPHOSPHAMIDE 3
6 CYCLOPHOSPHAMIDE FOR INJECTION 3
7 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 3
8 CYTARABINE 3
9 DEXAMETHASONE 3
See all common drugs associated with DISSEMINATED ENTEROVIRAL INFECTION

DISSEMINATED ENTEROVIRAL INFECTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OBINUTUZUMAB 8 0.0005
1 RITUXIMAB-ABBS 1 0.0002
2 BENDAMUSTINE HCL 3 0.0002
3 BENDAMUSTINE HYDROCHLORIDE 1 0.0001
4 AMITRIPTYLINE HYDROCHLORIDE 2 0.0001
5 VINCRISTINE SULFATE 3 0.0001
6 DOXORUBICIN HYDROCHLORIDE 2 0.0001
7 OFATUMUMAB 2 0.0001
8 CYTARABINE 3 0.0000
9 OCRELIZUMAB 3 0.0000
See all drugs enriched for association with DISSEMINATED ENTEROVIRAL INFECTION

DISSEMINATED ENTEROVIRAL INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 BCL-2 Inhibitor [EPC] 3 0.0000
1 CD20-directed Cytolytic Antibody [EPC] 11 0.0000
2 Tetracycline-class Drug [EPC] 1 0.0000
3 Alkylating Drug [EPC] 3 0.0000
4 Platinum-based Drug [EPC] 3 0.0000
5 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
6 Purine Antimetabolite [EPC] 1 0.0000
7 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
8 Corticosteroid [EPC] 8 0.0000
9 Kinase Inhibitor [EPC] 3 0.0000
See all drug classes enriched for association with DISSEMINATED ENTEROVIRAL INFECTION